In adults with active cancer and VTE, extended reduced-dose apixaban was noninferior to full-dose apixaban for VTE recurrence at 1 y.
Where this comes from
- Record sourced from PubMed, PMID 40759010.
- Also identified by DOI 10.7326/ANNALS-25-02426-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text] Oncology: [Formula: see text] Hematology: [Formula: see text].
Medical subject headings
- Pyridones
- Pyrazoles
- Venous Thromboembolism
- Factor Xa Inhibitors
- Neoplasms